Fierce Biotech1 min read
saveStryker appoints Spencer Stiles as CEO, Kevin Lobo to become Executive Chair
read at Fierce Biotech ↗Neutral
Stryker announced a leadership change, naming Spencer Stiles as the new chief executive officer.
Stiles, who has been president and COO, will also join the board. Kevin Lobo, who has led the company since 2012, will shift to the role of executive chair of the board effective Jan. 1, 2027.
Lobo’s tenure saw the company’s net sales grow from $8.7 billion in 2012 to over $26 billion in 2026, expanding its portfolio and global reach. He praised Stiles’ leadership and the board’s succession planning.
source
This writeup was produced by pharmadog from original reporting by Fierce Biotech.
Original headline: “Stryker strikes up a new CEO in Spencer Stiles as Kevin Lobo moves upstairs”
read at Fierce Biotech ↗441 words · retrieved 1h ago
comments(0)
5-min edit window · permanent after that